Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111806) titled 'Intravenous Tirofiban After Delayed Thrombolysis in Stroke' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Condition:
Acute Ischemic Stroke
Intervention:
Drug: Tirofiban
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: December 1, 2025
Target Sample Size: 852
Countries of Recruitment:
China
To know more, visit https://clinical...